<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903042</url>
  </required_header>
  <id_info>
    <org_study_id>Shanghai1stAI</org_study_id>
    <nct_id>NCT03903042</nct_id>
  </id_info>
  <brief_title>Comparison of Aurora Fundus Camera With Traditional Camera in Diabetic Retinopathy With Visual Artificial Intelligence</brief_title>
  <official_title>Comparison of Aurora Fundus Camera With Traditional Fundus Camera in Diabetic Retinopathy With Phoebus Visual Artificial Intelligence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the effect of Aurora handheld fundus camera with traditional
      desktop fundus camera in the fundus photography screening of diabetic patients, and to
      evaluate the effect of artificial intelligence algorithm in the diagnosis of diabetic
      retinopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aurora handheld fundus cameras are used to take fundus photography on diabetic patients in 3
      ophthalmic diabetic retinopathy screening centers in China to compare its effect with the
      hospital's traditional desktop fundus camera, and evaluate the auxiliary diagnostic effect of
      Phoebus artificial intelligence algorithm in diabetic retinopathy.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Image Quality of Aurora camera</measure>
    <time_frame>within 3 months</time_frame>
    <description>Score of Image Quality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outcome of gold standard</measure>
    <time_frame>within 3 months</time_frame>
    <description>Gold standard: 8 photographs of one patient(4 by Aurora camera, 4 by traditional camera) by ophthalmologist（double blinded）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image of Aurora camera</measure>
    <time_frame>1 month</time_frame>
    <description>Images taken by Aurora camera</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image of traditional camera (Center 1: Canon)</measure>
    <time_frame>1 month</time_frame>
    <description>Image taken by traditional camera（Center 1: Canon, pupil not dilated）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image of traditional camera (Center 2: Zeiss)</measure>
    <time_frame>1 month</time_frame>
    <description>Image taken by traditional camera（Center 2: Zeiss, pupil dilated）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image of traditional camera (Center 3: Topcon)</measure>
    <time_frame>1 month</time_frame>
    <description>Image taken by traditional camera（Center 3: Topcon, pupil dilated）</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcome of artificial intelligence algorithm</measure>
    <time_frame>3 months</time_frame>
    <description>Outcome of artificial intelligence algorithm(Normal or Referral Required)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Center 1: Traditional camera(Canon) vs Aurora camera</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Center 2: Traditional camera(Zeiss) vs Aurora camera</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Center 3: Traditional camera(Topcon) vs Aurora camera</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who were diagnosed with diabetes, more than 18 years of age, male or female
        Chinese patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participants are more than 18 years of age, male or female Chinese patients;

          2. Diagnosed with diabetes;

          3. Prior written informed consent should be obtained

        Exclusion Criteria:

          1. Patients with invisible fundus caused by any cause;

          2. Patients or his/her licensor unwill to sign an informed consent or follow this
             protocol;

          3. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fenghua Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Jin G, Xiao W, Ding X, Xu X, An L, Congdon N, Zhao J, He M. Prevalence of and Risk Factors for Diabetic Retinopathy in a Rural Chinese Population: The Yangxi Eye Study. Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5067-5073. doi: 10.1167/iovs.18-24280.</citation>
    <PMID>30357401</PMID>
  </reference>
  <reference>
    <citation>Zheng X, Zhang L. A study of retinopathy analysis in type 2 diabetes patients in Chinese population. Pak J Pharm Sci. 2018 Sep;31(5(Supplementary)):2041-2046.</citation>
    <PMID>30393210</PMID>
  </reference>
  <reference>
    <citation>Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic Retinopathy. Prim Care. 2015 Sep;42(3):451-64. doi: 10.1016/j.pop.2015.05.005. Review.</citation>
    <PMID>26319349</PMID>
  </reference>
  <reference>
    <citation>Wong TY, Bressler NM. Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening. JAMA. 2016 Dec 13;316(22):2366-2367. doi: 10.1001/jama.2016.17563.</citation>
    <PMID>27898977</PMID>
  </reference>
  <reference>
    <citation>Abramoff MD, Niemeijer M, Russell SR. Automated detection of diabetic retinopathy: barriers to translation into clinical practice. Expert Rev Med Devices. 2010 Mar;7(2):287-96. doi: 10.1586/erd.09.76.</citation>
    <PMID>20214432</PMID>
  </reference>
  <reference>
    <citation>Li Z, Keel S, Liu C, He Y, Meng W, Scheetz J, Lee PY, Shaw J, Ting D, Wong TY, Taylor H, Chang R, He M. An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs. Diabetes Care. 2018 Dec;41(12):2509-2516. doi: 10.2337/dc18-0147. Epub 2018 Oct 1.</citation>
    <PMID>30275284</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Fenghua Wang</investigator_full_name>
    <investigator_title>Doctoral Investigator</investigator_title>
  </responsible_party>
  <keyword>Aurora fundus camera</keyword>
  <keyword>Artificial intelligence</keyword>
  <keyword>Diabetic retinopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Clinical Study Report will be published</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>starting 6 months after publication</ipd_time_frame>
    <ipd_access_criteria>Dr Fenghua Wang will review requests and criteria.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

